Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 11, 16:00
2815.05
-5.6 (-0.2%)
VOLUME 3,688
LIVE
NSE
Nov 11, 16:00
2815.75
-6.35 (-0.23%)
VOLUME 306,664
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Prefer Dr Reddy's Laboratories, says Sukhani 

9.40 am | 31 Dec 2014 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com, one may prefer Dr Reddy's Laboratories....

Sun's margins may reduce to 30-32% post merger: Surajit Pal 

12.36 pm | 29 Dec 2014 |  Source: CNBC-TV18

As 2014 comes to an end, Surajit Pal of Prabhudas Lilladher shares his outlook on the year that was and the possible trends for 2015....

Avoid IT, pharma space: Andrew Holland 

11.09 am | 27 Dec 2014 |  Source: CNBC-TV18

Andrew Holland of Ambit Investment is of the view that one may avoid IT, pharma and consumer space....

Pick Dr Reddy's Laboratories: Phani Sekhar 

4.57 pm | 26 Dec 2014 |  Source: CNBC-TV18

Phani Sekhar of Angel Broking is of the view that one may pick Dr Reddy's Laboratories....

Avoid Dr Reddy's Laboratories: Sudarshan Sukhani 

4.54 pm | 24 Dec 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may avoid Dr Reddy's Laboratories....

Buy Dr Reddy’s Laboratories, says Sudarshan Sukhani 

9.35 am | 22 Dec 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advises buying Dr Reddy’s Laboratories....

Dr Reddy's acquires Habitrol brand

3.51 pm | 19 Dec 2014 |  Source: PTI

According to a statement issued by the drug major, the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal pat...

Prefer Asian Paints for long term: Sudarshan Sukhani 

5.04 pm | 17 Dec 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Asian Paints for long term....

Here are top 10 stocks to keep an eye on December 17 

9.03 am | 17 Dec 2014 |  Source: CNBC-TV18

Here are top 10 stocks to keep an eye on December 17 - Infosys, Zee Entertainment, Tata Steel, Dr Reddy's, Jagran Prakashan, Reliance Capital, Bharti ...

Dr Reddy's launches generic anti-viral tablets in US market

4.41 pm | 16 Dec 2014 |  Source: PTI

The company has launched Valganciclovir tablets, USP in the strength of 450 mg in the US market on December 15, 2014 and the product has been approved...

Dr. Reddy's launches Valganciclovir Tablets, USP

11.45 am | 16 Dec 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories announced today that it has launched Valganciclovir Tablets USD 450 mg, a therapeutic equivalent version of VALCYTE tablets in...

Here are top 10 stocks to focus on December 15 

8.50 am | 15 Dec 2014 |  Source: CNBC-TV18

Here are top 10 stocks to focus on December 15 – Mahindra and Mahindra (M&M), HCL Technologies, India Cement, Gas Authority of India (GAIL), Tata Co...

Book profits in Alembic: Sudarshan Sukhani 

12.12 pm | 11 Dec 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends booking profits in Alembic and advises switching to Sun Pharma or Dr Reddy's Labs....

AstraZeneca, Ranbaxy prevail in Nexium antitrust trial

2.14 pm | 06 Dec 2014 |  Source: Reuters

The US Federal Trade Commission estimates that pay-for-delay deals, in which a branded drugmaker pays a generic rival to stay off the market, cost con...

Approval for more than 60 ANDAs pending: DRL 

6.28 pm | 05 Dec 2014 |  Source: CNBC-TV18

Over the last few months there have been 5 or 6 audits. Since DRL has invested quite significantly in terms of the cultural transformation in quality ...

Here are top 10 stocks to focus on December 4 

9.01 am | 04 Dec 2014 |  Source: CNBC-TV18

Here are top 10 stocks to focus on December 4 - Ashok Leyland, Apollo Tyres, NBCC, HDFC Bank, ICICI Bank, MBL Infra, SAIL, Ranbaxy, Dr Reddy's and Sad...

US court refuses Ranbaxy plea to block ANDA nod for 2 drugs

2.34 pm | 26 Nov 2014 |  Source: PTI

Ranbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market....

Dr. Reddy's launches Docetaxel Injection USP

12.02 pm | 24 Nov 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched Docetaxel Injection USP 20 mg/ml and 50 mg/ml a therapeutic equivalent generic version of TAXOTERE in the US mark...

Dr Reddy's Laboratories launched over-the-counter Fexofenadine Hydrochloride

3.37 pm | 20 Nov 2014 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched its over-the-counter Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg/...

Sun Pharma, Lupin, Dr Reddy's preferred picks: Agarwal 

2.29 pm | 20 Nov 2014 |  Source: CNBC-TV18

According to Nitin Agrawal - Pharma Analyst at IDFC Securities, Sun Pharma, Lupin and Dr Reddy's labs are the preferred picks....

1 2 3 4 5 6 7 8 9 10
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.